{
  "symbol": "JNJ",
  "name": "Johnson & Johnson",
  "sector": "Health Care",
  "industry": "Pharmaceuticals",
  "date_added": "1973-06-30",
  "headquarters": "New Brunswick, New Jersey",
  "founded": "1886",
  "market_cap": 373662.67904,
  "pe_ratio": 17.27475,
  "forward_pe": 14.650943,
  "eps": 8.99,
  "revenue": 89330.999296,
  "profit_margin": 0.24415001,
  "debt_to_equity": 66.896,
  "return_on_equity": 0.29447,
  "dividend_yield": 3.4,
  "current_price": 155.3000030517578,
  "year_high": 168.54507794140187,
  "year_low": 138.3765537872536,
  "price_change_1d": -0.3145197095394027,
  "price_change_1w": -0.39763668834559085,
  "price_change_1m": 1.0672909999759688,
  "description": "Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizophrenia; oncology, such as prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; cardiovascular and metabolism, including thrombosis, diabetes, and macular degeneration; and pulm",
  "website": "https://www.jnj.com",
  "employees": 138100,
  "exchange": "NYQ",
  "currency": "USD",
  "analyst_target_price": 169.18262,
  "recommendation": null,
  "number_of_analysts": 23,
  "earnings_history": [],
  "analyst_data": {
    "target_high": 185.0,
    "target_low": 150.0,
    "target_mean": 169.18262,
    "target_median": 167.2
  },
  "last_updated": "2025-07-09T11:24:06.324390",
  "data_quality": {
    "has_financial_data": true,
    "has_earnings_data": false,
    "has_analyst_data": true,
    "completeness_score": 0.6666666666666666
  }
}